Clinical implications of mitochondrial DNA quantification on pregnancy outcomes: a blinded prospective non-selection study-Reference-Cited by-同舟云学术

Clinical implications of mitochondrial DNA quantification on pregnancy outcomes: a blinded prospective non-selection study

Author:

Fragouli Elpida¹²,McCaffrey Caroline³,Ravichandran Krithika⁴,Spath Katharina¹,Grifo James A³,Munné Santiago⁴,Wells Dagan¹²

Affiliation:

1. University of Oxford, Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Oxford OX3 9DU, UK

2. Reprogenetics UK (CooperGenomics), a Cooper Surgical Company, Institute for Reproductive Sciences, Oxford Business Park North, Oxford OX4 2HW, UK

3. NYU Langone Medical Center, 333 E 38th St, New York, NY 10016, USA

4. Reprogenetics (CooperGenomics), a Cooper Surgical Company, 3 Regent Street, Livingston, NJ 07039, USA

Funder

institutional funding (Reprogenetics and Reprogenetics UK)

National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme

Publisher

Oxford University Press (OUP)

Subject

Obstetrics and Gynecology,Rehabilitation,Reproductive Medicine

Link

Reference33 articles.

2. The mitochondrial DNA content of cumulus granulosa cells is linked to embryo quality;Desquiret-Dumas;Hum Reprod,2017

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献